Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma
Clinical trial NCT02186834 · COMPLETED
Trial details
- NCT number
- NCT02186834
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-23
- Primary completion
- 2017-11-08
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.